Sequence information
Variant position: 141 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 1480 The length of the canonical sequence.
Location on the sequence:
IYLGIGLCLLFIVRTLLLHP
A IFGLHHIGMQMRIAMFSLIY
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human IYLGIGLCLLFIVRTLLLHPA IFGLHHIGMQMRIAMFSLIY
Gorilla IYLGIGLCLLFIVRTLLLHPA IFGLHHIGMQMRIAMFSLIY
Rhesus macaque IYLGIGLCLLFIVRTLLLHPA IFGLHHIGMQMRIAMFSLIY
Chimpanzee IYLGIGLCLLFIVRTLLLHPA IFGLHHIGMQMRIAMFSLIY
Mouse IYLGIGLCLLFIVRTLLLHPA IFGLHRIGMQMRTAMFSLIY
Rat IYLGIGLCLLFIVRTLLLHPA IFGLHHIGMQMRIAMFSLIY
Pig IYLGVGLCLLFIVRTLLLHPA IFGPHHIGMQMRIAMFSLIY
Bovine IYLGIGLCLLFIVRTLLLHPA IFGLHHIGMQMRIAMFSLIY
Rabbit IYLGIGLCLLFVVRTLLLHPA IFGLHHIGMQMRIAMFSLIY
Sheep IYLGIGLCLLFIVRTLLLHPA IFGLHHIGMQMRIAMFSLIY
Horse IYLGIGLCLLFIVRTLLLHPA IFGLHHIGMQMRIAMFSLIY
Xenopus laevis YYLAIGLCLLFVVRMLLLHPA IFGLHHIGMQMRIAMFSLIY
Zebrafish YFLAFGLGLLFTARFLLLQPA MFGLHHLGMQIRIALFSIIY
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 1480
Cystic fibrosis transmembrane conductance regulator
Transmembrane
123 – 146
Helical; Name=2
Domain
81 – 365
ABC transmembrane type-1 1
Helix
120 – 164
Literature citations
Novel mutation (A141D) in exon 4 of the CFTR gene identified in an Algerian patient.
Gouya L.; Pascaud O.; Munck A.; Elion J.; Denamur E.;
Hum. Mutat. 10:86-87(1997)
Cited for: VARIANT CF ASP-141;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.